bladder cancer Diatech, Janssen Partner to Develop Molecular Diagnostics for Bladder Cancer The bladder cancer test in development will profile genetic alterations in bladder cancer in three hours using real-time PCR. New Bladder Cancer Molecular Classification Predicts Response to Common Immunotherapy The new subtypes could help clinicians pick alternative therapies for patients unlikely to respond to Bacillus Calmette-Guérin treatment. Convergent Genomics Building Data on Urine-Based Assay to Diagnose, Monitor Urothelial Carcinoma Premium The Oregon Health and Science University spinout also recently presented data suggesting the test could help predict future urothelial carcinoma. GeneCentric Begins Study to Validate RNA Gene Signature Test in Bladder Cancer GeneCentric investigators will assess the ability of the FGFR predictive response signature to identify bladder cancer patients who may benefit from targeted therapy. Culmination Bio, Cofactor Genomics Team up on Study to Advance Immunotherapy Response Test Culmination will give Cofactor access to over 4.5 million biological samples to advance the firm's assay to predict immunotherapy response in 11 cancer types. May 4, 2023 Nucleix Bladder EpiCheck Cancer Liquid Biopsy Test Gets FDA 510(k) Clearance Apr 28, 2023 Pacific Edge Ramps up Clinical Utility Studies, Commercial Efforts Behind Bladder Cancer Test Premium Mar 24, 2023 British Liquid Biopsy Firm Nonacus Launches Urine-Based Bladder Cancer Assay Premium Feb 15, 2023 NeoGenomics Eyes Bladder Cancer as Future Indication for Radar MRD Test Premium Nov 30, 2022 Bladder Cancer Genomic Landscape Study Aims to Engender New Biomarker-Guided Therapies Premium Nov 2, 2022 Diagnostics Developer Early is Good Raises $4M in Seed Funding Jul 11, 2022 Immune Checkpoint Blockade Response Linked to Recurrent Mutations in Genes, Pathways Jun 23, 2022 Nucleix Expands EU Label Indication for Bladder Cancer Urine Test May 23, 2022 Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership Aug 31, 2021 Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease Jul 1, 2021 European Consortium Nets €1M for Test to Predict Bladder Cancer Immunotherapy Response Jul 1, 2021 University of Birmingham, Nonacus to Develop Urine Cancer Liquid Biopsy Assay Jun 18, 2021 Natera Aims to Lead Market in Solid Tumor Adjuvant CDx, Supported by New Liquid Biopsy Data Premium Jun 4, 2021 Veracyte Bladder Cancer Test Receives Medicare Coverage Apr 16, 2021 OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence Premium Apr 12, 2021 Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor Apr 9, 2021 Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers Apr 8, 2021 Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx Premium Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Mar 15, 2021 OncoDiag Raises $3M to Market Test for Early Detection of Recurrent Bladder Cancer Load More Breaking News SARS-CoV-2 Variants of Concerns Evolved to Modify Host Immune Response, Multiomics Study Shows People in the News at GA4GH, Mercy BioAnalytics, Deepcell, One Biosciences New Products Posted to GenomeWeb: Clinical Microbiomics, Integra Biosciences, DNAstack, Bruker Angolan Namib Desert Population Analysis Uncovers New Ancestry Group With Deep Divergence Cedars-Sinai Sets Up $25M Single Cell Precision Medicine Center The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.